Ecolab Inc. (ECL) was reiterated a ‘Buy’ by Canaccord Genuity analysts on Wednesday. The broker also raised its price target on the stock to $128 from $120.
On valuation measures, Ecolab Inc. shares are currently priced at 30.67x this year’s forecasted earnings compared to the industry’s 16.21x earnings multiple. Ticker has a PEG and forward P/E ratio of 1.70 and 21.60, respectively. Price/Sales for the same period is 2.40 while EPS is $3.76. Currently there are 8 analysts that rate ECL a ‘Buy’, 5 rate it a ‘Hold’. No analyst rates it a ‘Sell’. ECL has a median Wall Street price target of $123.00 with a high target of $135.00.
In the past 52 weeks, shares of St. Paul, Minnesota-based company have traded between a low of $97.78 and a high of $118.46 and are now at $115.27. Shares are up 11.54% year-over-year and up 8.11% year-to-date.
The Rubicon Project, Inc. (RUBI) was reiterated as ‘Outperform’ with a $26 from $18 price target on Wednesday by Oppenheimer.
RUBI, currently valued at $726.84 million, has a median Wall Street price target of $20.00 with a high target of $23.00. Approximately 2.03M shares have already changed hands, well above the issue’s 272.42K average for a full session over the past 3 months.
In the past 52 weeks, shares of Los Angeles, California-based technology company have traded between a low of $8.76 and a high of $23.20 with the 50-day MA and 200-day MA located at $15.74 and $13.10 levels, respectively. Additionally, shares of RUBI trade at a P/E ratio of -3.43 and have a Relative Strength Index (RSI) and MACD indicator of 77.69 and +1.98, respectively.
RUBI currently prints a one year gain of less than one percent, and and a year-to-date return of around 10.80%.
Whole Foods Market, Inc. (WFM) rating of ‘Outperform’ was reiterated today at Oppenheimer with a price target increase of $65 from $62 (versus a $56.68 previous close).
WFM shares recently lost $0.09 to $56.59. In the past 52 weeks, shares of the retailer of natural and organic food have traded between a low of $36.08 and a high of $57.57. Shares are up 8.37% year-over-year and 12.71% year-to-date.
Shares of SM Energy Company (SM) are up $6.30 to $52.56 in mid-day trading after UBS reiterated its ‘Neutral’ rating and increased its 12-month base case estimate on the name by 7 points to $48 a share.
SM shares are down nearly 37% year-over-year and roughly 20% year-to-date. In the past 12 months, shares of Denver, Colorado-based independent energy company have traded between a low of $29.41 and a high of $90.38.
SM Energy Company closed Tuesday at $46.26. The name has a total market cap of $3.55 billion.
Actavis plc (ACT) was reiterated as ‘Outperform’ and the price target was increased to $350 from $315 at Bernstein.
ACT shares recently gained $1.32 to $290.43. Bernstein’s target price suggests a potential upside of about 21% from the company’s current stock price.
In the past 52 weeks, shares of Parsippany, New Jersey-based pharmaceutical company have traded between a low of $184.71 and a high of $296.77. Shares are up 30.01% year-over-year and 12.31% year-to-date.
Northland Capital this morning raised its price target on Zagg Inc (ZAGG) to $7.75 from $7.50, and reiterated an ‘Outperform’ rating.
Currently there are 3 analysts that rate ZAGG a ‘Buy’, 2 rate it a ‘Hold’. No analyst rates it a ‘Sell’. ZAGG has a median Wall Street price target of $7.50 with a high target of $9.25.
In the past 52 weeks, shares of Salt Lake City, Utah-based firm have traded between a low of $4.17 and a high of $7.46 and are now at $7.15. Shares are up 53.26% year-over-year ; down 2.95% year-to-date.